News
-
-
-
COMMUNIQUÉ DE PRESSE
BioVersys publishes Invitation to its ANNUAL GENERAL MEETING OF SHAREHOLDERS 2025
BioVersys AG publishes Invitation to its Annual General Meeting of Shareholders 2025, including agenda with items such as annual report, elections, compensation approval, and capital range amendment -
-
-
COMMUNIQUÉ DE PRESSE
BioVersys to Host Virtual KOL Event to Discuss BV100 Phase 2 Ventilator Associated Pneumonia (VABP) Study Against Carbapenem Resistant Acinetobacter on May 7, 2025
BioVersys AG to host virtual KOL event featuring Prof. David Paterson & Dr. Andrew Shorr on BV100 Phase 2 VABP study against CRAB. Register for insights on May 7, 2025 -
-
-
-